Core Points - The company has completed the issuance of 11,873,817 new shares, which were registered and managed on September 25, 2025, and will be tradable on the Shanghai Stock Exchange after the lock-up period ends [1][14] - The issuance will not change the company's control and complies with the listing conditions of the Shanghai Stock Exchange [2][23] - The total amount raised from this issuance is approximately RMB 3.76 billion, with a net amount of approximately RMB 3.73 billion after deducting issuance costs [8][13] Issuance Overview - The issuance involved 11,873,817 shares at a price of RMB 317.00 per share, resulting in a total fundraising amount of RMB 3,763,999,989.00 [8][12] - The issuance process followed necessary internal decision-making procedures and received approval from the board and shareholders [3][4] - The shares were issued to specific investors and are subject to a six-month lock-up period [9][19] Regulatory Approval - The issuance received approval from the Shanghai Stock Exchange on July 11, 2025, and from the China Securities Regulatory Commission on August 7, 2025 [4][10] Financial Impact - The issuance will increase the company's total assets and net assets, leading to a decrease in the debt-to-asset ratio, thereby enhancing the company's financial strength and debt repayment capability [24] - The capital structure will be optimized, providing effective support for future development [24] Shareholder Structure - The issuance will not result in significant changes to the company's business structure or governance, and the controlling shareholder remains unchanged [25][26] - The issuance was conducted fairly and in compliance with relevant laws, ensuring that no major shareholders or related parties were involved in the subscription process [18][22] Underwriters and Legal Advisors - The main underwriter for this issuance is CITIC Securities Co., Ltd., with joint underwriters including Huatai United Securities and Goldman Sachs (China) Securities [10][11]
四川百利天恒药业股份有限公司关于向特定对象发行股票发行结果暨股本变动的公告